Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study
Clin. Cancer Res., 2022 Aug 15;28(16):3489-3498 | https://doi.org/10.1158/1078-0432.CCR-22-0121